These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1511228)

  • 21. A pilot study of naltrexone-accelerated detoxification in opioid dependence.
    Bell JR; Young MR; Masterman SC; Morris A; Mattick RP; Bammer G
    Med J Aust; 1999 Jul; 171(1):26-30. PubMed ID: 10451668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma testosterone levels during chronic heroin use and protracted astinence. A study of Hong Kong addicts.
    Mendelson JH; Mello NK
    Clin Pharmacol Ther; 1975 May; 17(5):529-33. PubMed ID: 1126110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonidine improved laboratory-measured decision-making performance in abstinent heroin addicts.
    Zhang XL; Wang GB; Zhao LY; Sun LL; Wang J; Wu P; Lu L; Shi J
    PLoS One; 2012; 7(1):e29084. PubMed ID: 22291886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin.
    Camí J; de Torres S; San L; Solé A; Guerra D; Ugena B
    Clin Pharmacol Ther; 1985 Sep; 38(3):336-41. PubMed ID: 4028630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans.
    Kreek MJ; Wardlaw SL; Hartman N; Raghunath J; Friedman J; Schneider B; Frantz AG
    Life Sci; 1983; 33 Suppl 1():409-11. PubMed ID: 6319894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
    Bickel WK; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1988 Jan; 43(1):72-8. PubMed ID: 3275523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
    Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
    Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma testosterone levels in heroin addiction and during methadone maintenance.
    Mendelson JH; Mendelson JE; Patch VD
    J Pharmacol Exp Ther; 1975 Jan; 192(1):211-17. PubMed ID: 1123724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in adrenocorticotropic hormone (ACTH) and cortisol levels in drug addicts treated by a new and rapid detoxification procedure using acupuncture and naloxone.
    Wen HL; Ho WK; Wong HK; Mehal ZD; Ng YH; Ma L
    Comp Med East West; 1979; 6(3):241-5. PubMed ID: 225122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Hair Cortisol Levels among Heroin Addicts on Current Methadone Maintenance Compared to Controls.
    Yang J; Li J; Xu G; Zhang J; Chen Z; Lu Z; Deng H
    PLoS One; 2016; 11(3):e0150729. PubMed ID: 27010803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naltrexone shortened opioid detoxification with buprenorphine.
    Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
    Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study.
    Uhde TW; Redmond DE; Kleber HD
    Psychiatry Res; 1980 Mar; 2(1):37-47. PubMed ID: 6932053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Ge Y; Li M; Sun WL; Cai ZJ
    Yao Xue Xue Bao; 1994; 29(4):256-60. PubMed ID: 7976340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of heroin withdrawal with guanfacine: an open clinical investigation.
    Soler Insa PA; Bedate Villar J; Theohar C; Yotis A
    Can J Psychiatry; 1987 Nov; 32(8):679-82. PubMed ID: 2891431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 39. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
    Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
    Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
    Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.